The European Medicines Agency review of eltrombopag (Revolade) for the treatment of adult chronic immune (idiopathic) thrombocytopenic purpura: summary of the scientific assessment of the Committee for Medicinal Products for Human Use - Nieto, M; Calvo, G; Hudson, I (Haematologica, 2011)
et al.